Balchem (BCPC) Stock Overview
Develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for BCPC from our risk checks.
BCPC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Balchem Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$156.34 |
| 52 Week High | US$185.96 |
| 52 Week Low | US$145.70 |
| Beta | 0.93 |
| 1 Month Change | -2.54% |
| 3 Month Change | -2.29% |
| 1 Year Change | -9.01% |
| 3 Year Change | 26.88% |
| 5 Year Change | 61.23% |
| Change since IPO | 62,384.51% |
Recent News & Updates
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 26
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital
Jul 21Balchem Corporation: The Next Earnings Release Should Guide Investors
Jul 14These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23Recent updates
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 26Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital
Jul 21Balchem Corporation: The Next Earnings Release Should Guide Investors
Jul 14These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23When Should You Buy Balchem Corporation (NASDAQ:BCPC)?
May 26Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 17We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Mar 21Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing
Mar 07A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jan 30Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Dec 06Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07
Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion
Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.Balchem: A Tale Of Two Businesses
May 10Balchem: Potential Turnaround Is In The Price
Feb 21Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Shareholder Returns
| BCPC | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -3.0% | 0.3% | 1.7% |
| 1Y | -9.0% | -5.6% | 18.7% |
Return vs Industry: BCPC underperformed the US Chemicals industry which returned -5.7% over the past year.
Return vs Market: BCPC underperformed the US Market which returned 18.5% over the past year.
Price Volatility
| BCPC volatility | |
|---|---|
| BCPC Average Weekly Movement | 2.7% |
| Chemicals Industry Average Movement | 6.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BCPC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BCPC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,364 | Ted Harris | www.balchem.com |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Corporation Fundamentals Summary
| BCPC fundamental statistics | |
|---|---|
| Market cap | US$5.07b |
| Earnings (TTM) | US$142.75m |
| Revenue (TTM) | US$985.93m |
Is BCPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BCPC income statement (TTM) | |
|---|---|
| Revenue | US$985.93m |
| Cost of Revenue | US$632.95m |
| Gross Profit | US$352.98m |
| Other Expenses | US$210.23m |
| Earnings | US$142.75m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.40 |
| Gross Margin | 35.80% |
| Net Profit Margin | 14.48% |
| Debt/Equity Ratio | 15.0% |
How did BCPC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/14 14:37 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Balchem Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |